![vTv Therapeutics](https://microsmallcap.com/wp-content/uploads/2017/12/Is-vTv-Therapeutics-Making-a-Comeback-Stock-up-Almost-40-Despite-Plunging-on-Dec.-25-374x295.jpg)
Biotechnology
Is vTv Therapeutics Making a Comeback? Stock up Almost 40% Despite Plunging on Dec. 25
The general consensus surrounding stocks and the market is that it can be an extremely volatile environment, and it seems that vTv Therapeutics, Inc. (NASDAQ:VTVT) is living up to that reputation, and it is important ... [Read]
![Auris Medical Holding](https://microsmallcap.com/wp-content/uploads/2017/12/Auris-Medical-Holding-to-Provide-Update-on-Development-Program-with-AM-111-Stock-Jumps-Almost-30-374x295.png)
Biotechnology
Auris Medical Holding to Provide Update on Development Program with AM-111, Stock Jumps Almost 30%
The market may have just started to pick up its stride, but Auris Medical Holding AG (NASDAQ:EARS) has already grabbed the attention of a number of investors as it is up, as of this writing, ... [Read]
![Ignyta, Inc. Under Investigation](https://microsmallcap.com/wp-content/uploads/2017/12/Why-is-Ignyta-Inc.-Under-Investigation-After-Signing-Deal-with-Roche-Holding-374x260.jpg)
Biotechnology
Why is Ignyta, Inc. Under Investigation After Signing Deal with Roche Holding?
Ignyta, Inc. (NASDAQ:RXDX) stock has surged today on the news of its buyout from big-time cancer research company Roche Holding Ltc (OTCQX:RHHBF). While everything started off smoothly on this deal, suspicions have arisen that Ignyta’s ... [Read]
![QBioMed Inc](https://microsmallcap.com/wp-content/uploads/2017/12/Screenshot-2017-12-22-at-7.03.49-AM-Edited-374x295.png)
Biotechnology
Q BioMed Inc. Shares Up 10%, As Company Announces Big Movements In 2018 With Cancer Aid Drug
The New York-based Biotech accelerator, Q BioMed Inc. (OTCQB:QBIO) saw its shares rise 10.96%, to $4.05 each. Of its latest four projects in the works, the most ‘revenue ready’ is the Strontium Chloride 89 (SR89) ... [Read]
![Corcept Therapeutics](https://microsmallcap.com/wp-content/uploads/2017/12/Corcept-Therapeutics-Joins-the-SP-SmallCap-600-Stock-Rises-11-374x295.png)
Biotechnology
Corcept Therapeutics Joins the S&P SmallCap 600, Stock Rises 11%
Corcept Therapeutics Incorporated (NASDAQ:CORT) has joined the S&P SmallCap 600, and as a result, the stocks have jumped 11%. Currently, Corcept shares are sitting at $17.59, which is up $1.79, or 11.33%, from Wednesday’s close ... [Read]
![](https://microsmallcap.com/wp-content/uploads/2017/12/A-Look-Into-Whats-Causing-MYM-Nutraceuticals-Stock-Growth-374x295.png)
Biotechnology
A Look Into What’s Causing MYM Nutraceuticals’ Stock Growth
MYM Nutraceuticals Inc. (OTCQB:MYMMF) (TSXV:MYM), a company that focuses on producing and selling medicinal marijuana, has seen its stock increase to $3.33 at the time of writing, which is up $0.58 (or 21%) from yesterday’s ... [Read]
![U.S. Tax Bill](https://microsmallcap.com/wp-content/uploads/2017/12/Eleven-Biotherapeutics-Reaping-the-Benefits-of-U.S.-Market-Shareholders-Awaiting-Vote-on-U.S.-Tax-Bill.-374x295.jpg)
Biotechnology
Eleven Biotherapeutics Reaping the Benefits of U.S. Market Shareholders Awaiting Vote on U.S. Tax Bill
On Monday, United States stocks closed at an all-time high. The reason? Investors were waiting to see the results of a bill which would, if passed, slash corporate taxes. Further, because of shareholders awaiting a ... [Read]
![Aratana Therapeutics](https://microsmallcap.com/wp-content/uploads/2017/12/Heres-Why-Aratana-Therapeutics-Stock-Dropped-Today-374x295.jpg)
Biotechnology
Here’s Why Aratana Therapeutics Stock Dropped Today
As of 1:16 p.m. EST on Tuesday, December 19, shares of Aratana Therapeutics, Inc. (NASDAQ:PETX) are down 1.79%. The company has a market capitalization of $236.07 million. This is not overly surprising considering the Leawood, ... [Read]
![prconnect, biotech investing, biotech investing news, biotech investments, biotech companies, investing in biotech companies, investing in biotech stocks, biotech invest, biotech investors, new biotech stocks, biotech stocks today, top biotech investors, investing in biotech, biotech sector etf, biotech stock analysis, biotech stocks, invest in biotech, best biotech companies to invest in, biotech stock research, biotech stock market. biotech investment, editorial, editorial, Healthcare, healthcare investing, investing in healthcare, healthcare investments, investing in healthcare mutual funds, investor healthcare, healthcare stocks to invest in, invest in healthcare, healthcare investor, healthcare investment, healthcare stocks today, healthcare investors, healthcare investment bank, healthcare mutual funds, healthcare savings, medicine stocks, healthcare industry companies, medical stocks, healthcare stock, health sector stocks, healthcare stock market, health services stocks,](https://microsmallcap.com/wp-content/uploads/2017/12/Spectrum-Pharmaceuticals-Terminates-CEO-Appoints-New-CEO-374x295.jpg)
Biotechnology
Spectrum Pharmaceuticals Terminates CEO, Appoints New CEO
Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) has terminated its CEO Rajesh Shrotriya and has appointed Joseph Turgeon as the company’s new CEO. Turgeon, who was previously the COO, will still maintain his position as President of the ... [Read]
![Biotech IPO](https://microsmallcap.com/wp-content/uploads/2017/12/Denali-Therapeutics-Raises-the-Years-Largest-Biotech-IPO-374x295.png)
Biotechnology
Denali Therapeutics Raises the Year’s Largest Biotech IPO
Denali Therapeutics (NASDAQ:DNLI) managed to raise $250 million at a post-money valuation of $1.58 billion. This has put Denali Therapeutics on the list for one of the largest biotechnology IPOs of 2017. If Denali is ... [Read]